Progress of targeted FOX family therapy in ovarian cancer
Ovarian cancer (OC) remains one of the most lethal malignancies affecting women, largely due to its asymptomatic onset and the consequent challenges in early detection and diagnosis. This often results in delayed treatment and poor clinical outcomes. Among gynecological cancers, OC exhibits the high...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1604998/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849715610220494848 |
|---|---|
| author | Hairong Zhang Cuiping Gong Xin Lv |
| author_facet | Hairong Zhang Cuiping Gong Xin Lv |
| author_sort | Hairong Zhang |
| collection | DOAJ |
| description | Ovarian cancer (OC) remains one of the most lethal malignancies affecting women, largely due to its asymptomatic onset and the consequent challenges in early detection and diagnosis. This often results in delayed treatment and poor clinical outcomes. Among gynecological cancers, OC exhibits the highest mortality rate. While current therapeutic approaches such as surgery and chemotherapy provide initial clinical benefit, they are frequently undermined by high rates of recurrence and metastasis. Moreover, the pronounced heterogeneity of OC further complicates treatment, highlighting the urgent need for novel therapeutic targets and more effective strategies. The forkhead box (FOX) family of transcription factors comprises a large group of proteins involved in regulating gene expression across various biological processes. Dysregulation of FOX family members has been implicated in aberrant cellular behaviors, including uncontrolled proliferation, resistance to apoptosis, enhanced invasiveness, metastatic potential, and the development of drug resistance. Importantly, the functional roles of individual FOX proteins vary significantly depending on the tumor context, reflecting the functional diversity of this family. This review aims to provide a comprehensive overview of the emerging roles of FOX family members in the pathogenesis and progression of OC, as well as recent advances in FOX-targeted therapeutic strategies. |
| format | Article |
| id | doaj-art-cf0de7e71ce4407ea7aa856d6a18c58d |
| institution | DOAJ |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-cf0de7e71ce4407ea7aa856d6a18c58d2025-08-20T03:13:18ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-07-011610.3389/fphar.2025.16049981604998Progress of targeted FOX family therapy in ovarian cancerHairong ZhangCuiping GongXin LvOvarian cancer (OC) remains one of the most lethal malignancies affecting women, largely due to its asymptomatic onset and the consequent challenges in early detection and diagnosis. This often results in delayed treatment and poor clinical outcomes. Among gynecological cancers, OC exhibits the highest mortality rate. While current therapeutic approaches such as surgery and chemotherapy provide initial clinical benefit, they are frequently undermined by high rates of recurrence and metastasis. Moreover, the pronounced heterogeneity of OC further complicates treatment, highlighting the urgent need for novel therapeutic targets and more effective strategies. The forkhead box (FOX) family of transcription factors comprises a large group of proteins involved in regulating gene expression across various biological processes. Dysregulation of FOX family members has been implicated in aberrant cellular behaviors, including uncontrolled proliferation, resistance to apoptosis, enhanced invasiveness, metastatic potential, and the development of drug resistance. Importantly, the functional roles of individual FOX proteins vary significantly depending on the tumor context, reflecting the functional diversity of this family. This review aims to provide a comprehensive overview of the emerging roles of FOX family members in the pathogenesis and progression of OC, as well as recent advances in FOX-targeted therapeutic strategies.https://www.frontiersin.org/articles/10.3389/fphar.2025.1604998/fullovarian cancerFOX familytargeted therapyFOXAFOXCFOXM |
| spellingShingle | Hairong Zhang Cuiping Gong Xin Lv Progress of targeted FOX family therapy in ovarian cancer Frontiers in Pharmacology ovarian cancer FOX family targeted therapy FOXA FOXC FOXM |
| title | Progress of targeted FOX family therapy in ovarian cancer |
| title_full | Progress of targeted FOX family therapy in ovarian cancer |
| title_fullStr | Progress of targeted FOX family therapy in ovarian cancer |
| title_full_unstemmed | Progress of targeted FOX family therapy in ovarian cancer |
| title_short | Progress of targeted FOX family therapy in ovarian cancer |
| title_sort | progress of targeted fox family therapy in ovarian cancer |
| topic | ovarian cancer FOX family targeted therapy FOXA FOXC FOXM |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1604998/full |
| work_keys_str_mv | AT hairongzhang progressoftargetedfoxfamilytherapyinovariancancer AT cuipinggong progressoftargetedfoxfamilytherapyinovariancancer AT xinlv progressoftargetedfoxfamilytherapyinovariancancer |